Clinical Trials Browser

Phase 2 × Interventional × Locally Advanced Non-Small Cell Lung Cancer × Clear all

NCT06837948 2025-02-20

Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC

Phase 2 Not yet recruiting

Locally Advanced Non-Small Cell Lung Cancer